" class="no-js "lang="en-US"> Foundation for Prader Willi Research (FPWR) - Medtech Alert
Tuesday, August 05, 2025
Foundation for Prader Willi Research (FPWR) | Pharmtech Focus

Foundation for Prader Willi Research (FPWR)

About Foundation for Prader Willi Research (FPWR)

Foundation for Prader Willi Research (FPWR)

FPWR is composed of thousands of parents, family members, researchers, and others who are interested in addressing the many issues related to PWS, including childhood obesity, developmental delays, psychiatric disorders, and autism spectrum disorders. The mission of FPWR is to eliminate the challenges of Prader-Willi syndrome through the advancement of research and therapeutic development. FPWR supports cutting edge research studies around the world to advance the understanding of PWS, and collaborates with research institutions, pharmaceutical companies and the FDA to advance new treatments that will help those with PWS. To date, FPWR has funded over $10 million in PWS research. For more information please visit https://www.fpwr.org/.

Related Story

Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led by Sorrento Therapeutics and Including Existing Investors and the Foundation for Prader-Willi Research

August 9 2021

Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing and commercializing novel small […]